The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Conjugated Oral versus Transdermal Estrogen Replacement in Girls with Turner Syndrome: A Pilot Comparative Study
Abstract
BACKGROUND: The optimal route of estrogen replacement in Turner syndrome (TS) is unknown. OBJECTIVE: The objective of the study was to compare conjugated oral vs. transdermal estrogen (TD E2) on bone accrual, uterine growth, pubertal development, IGF-I, and lipids in girls with TS. METHODS: Prepubertal GH-treated girls aged 10 yr or older with TS were eligible. Subjects were randomized to conjugated oral estrogen or TD E2 for 1 yr. Assessments included dual-emission x-ray absorptiometry, pelvic ultrasound, Tanner staging, growth velocity, IGF-I, and lipid profile. RESULTS: Twelve girls (14.0 +/- 1.7 yr) were enrolled. TD E2 resulted in a significantly greater change in spine bone density at 12 months compared with conjugated oral estrogen (bone mineral content 9.0 +/- 0.9 vs. 5.8 +/- 0.9 g, P = 0.04; bone mineral density 0.12 +/- 0.01 vs. 0.06 +/- 0.01 g/cm2, P = 0.004; Z-score 0.7 +/- 0.1 vs. 0.3 +/- 0.1, P = 0.03). Greater increases in uterine length (4.13 +/- 0.39 vs. 1.98 +/- 0.39 cm, P = 0.003) and volume (22.2 +/- 4.4 vs. 4.0 +/- 4.4 ml, P = 0.02) were also found in the TD vs. the oral group at 1 yr. At study end, 66% of subjects in the TD group had a mature uterus vs. 0% in the oral group. No significant differences in other parameters examined were seen. CONCLUSION: In girls with TS, TD E2 resulted in faster bone accrual at the spine and increased uterine growth compared with conjugated oral estrogen. This pilot study provides preliminary information for optimizing estrogen replacement in this population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies differ on whether oral E2 vs. TD E2 leads to increased total cholesterol and decreased HDL”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [335]
In the citing paper
“Earlier initiation of HRT does affect BMD with higher BMD/better bone quality/greater trabecular bone score”
From Clinical practice guidelines for the care of girls and women with Turner syndrome. (2024) · cites this paper as [335]
Citations
Cites
The Practice Committee of the American Society for Reproductive Medicine
Birmingham, A. (2006) · Cited by 1,925
A SYNDROME OF INFANTILISM, CONGENITAL WEBBED NECK, AND CUBITUS VALGUS1
TURNER, H. H. (1938) · Endocrinology · doi:10.1210/endo-23-5-566 · Cited by 1,124
Gravholt, C. H., Juul, S., Naeraa, R. W., & Hansen, J. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00237-0 · Cited by 548
Rosenfeld, R. G. (1990) · Cited by 501
Biologic Effects of Transdermal Estradiol
Chetkowski, R. J., Meldrum, D. R., Steingold, K. A., Randle, D., Lu, J. K., Eggena, P., Hershman, J. M., Alkjaersig, N. K., Fletcher, A. P., & Judd, H. L. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142505 · Cited by 482
Biologic effects of transdermal estradiol
Chetkowski, R. J., Meldrum, D., & Ka, S. (1987) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(87)90325-0 · Cited by 467
Turner's Syndrome in Adulthood
Elsheikh, M., Dunger, D. B., Conway, G. S., & Wass, J. A. H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0457 · Cited by 395
Accelerated germ cell apoptosis in sex chromosome aneuploid fetal human gonads
Modi, D. N. (2003) · Molecular Human Reproduction · doi:10.1093/molehr/gag031 · Cited by 256
Biological Effects of Estradiol-17β in Postmenopausal Women: Oral Versus percutaneous Administration
LIGNIERS, B. D., Basdevant, A., Thomas, G., Thalabard, J., Mercier-Bodard, C., Conard, J., Guyene, T.-T., MAIRON, N., Corvol, P. L., Guy-grand, B., et al. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-3-536 · Cited by 228
Pharmacokinetic and Pharmacologic Variation Between Different Estrogen Products
O’Connell, M. B. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04143.x · Cited by 186
Kelly, J. J., Rajkovic, I. A., O’Sullivan, A., Sernia, C., & Ho, K. K. Y. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb02410.x · Cited by 165
Osteoporosis and fractures in Turner syndrome–importance of growth promoting and oestrogen therapy
Landin‐Wilhelmsen, K., Bryman, I., Windh, M., & Wilhelmsen, L. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00841.x · Cited by 156
Musgrave, K. O., Giambalvo, L., Leclerc, H. L., Cook, R. A., & Rosen, C. J. (1989) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)02399-3 · Cited by 142
Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey
Gravholt, C. H., Vestergaard, P., Hermann, A. P., Mosekilde, L., Brixen, K., & Christiansen, J. S. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01807.x · Cited by 130
Ankarberg‐Lindgren, C., Elfving, M., Wikland, K. A., & Norjavaara, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7667 · Cited by 125
Rosenfield, R. L., Devine, N. A., Hunold, J. J., Mauras, N., Moshang, T., & Root, A. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1081 · Cited by 119
Oocyte donation in Turner's syndrome: an analysis of the factors affecting the outcome
Khastgir, G., Abdalla, H., Thomas, A. M., Korea, L., Latarche, L., & Studd, J. W. W. (1997) · Human Reproduction · doi:10.1093/humrep/12.2.279 · Cited by 97
A report on 100 cycles of oocyte donation; factors affecting the outcome
Abdalla, H., Baber, R., Kirkland, A., Leonard, T., Power, M., & Studd, J. W. W. (1990) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137209 · Cited by 90
Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome
(2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.042 · Cited by 85
Mazzanti, L., CACCIARI, E., Bergamaschi, R., Tassinari, D., Magnani, C., Perri, A., Scarano, E., & Pluchinotta, V. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70137-9 · Cited by 81
A Workshop on Pubertal Hormone Replacement Options in the United States
Drobac, S., Rubin, K., Rogol, A. D., & Rosenfield, R. L. (2006) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2006.19.1.55 · Cited by 80
Uterine Development in Turner Syndrome
Bakalov, V. K., Shawker, T. H., Ceniceros, I., & Bondy, C. A. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.04.031 · Cited by 78
Choosing an oestrogen replacement therapy in young adult women with Turner syndrome
Guttmann, H., Weiner, Z., Nikolski, E., Ish‐Shalom, S., Itskovitz‐Eldor, J., Aviram, M., Reisner, S., & Hochberg, Z. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01181.x · Cited by 78
Fracture risk and bone mineral density in Turner syndrome
Bakalov, V. K., & Bondy, C. A. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9076-2 · Cited by 70
Poor uterine development in Turner syndrome with oral oestrogen therapy
Paterson, W. F., Hollman, A. S., & Donaldson, M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01477.x · Cited by 69
Mauras, N., Shulman, D., Hsiang, H. Y., Balagopal, P., & Welch, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0671 · Cited by 65
The Uterine Length in Women with Turner Syndrome Reflects the Postmenarcheal Daily Estrogen Dose
Šnajderová, M., Mardešic, T., Lebl, J., Geržová, H., Teslík, L., & Zapletalová, J. (2003) · Hormone Research in Paediatrics · doi:10.1159/000073233 · Cited by 57
Doerr, H. G., Bettendorf, M., Hauffa, B. P., Mehls, O., Partsch, C., Said, E., Sander, S., Schwarz, H., Stahnke, N., Steinkamp, H., et al. (2005) · Human Reproduction · doi:10.1093/humrep/deh764 · Cited by 57
Comparison of transdermal and oral estrogen therapy in girls with Turner's syndrome
Jospe, N., Orlowski, C. C., & Furlanetto, R. W. (1995) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1995.8.2.111 · Cited by 54
The effects of prolonged physiologic estradiol therapy on the maturation of hypogonadal teen-agers
Rosenfield, R. L., & Fang, V. S. (1974) · The Journal of Pediatrics · doi:10.1016/s0022-3476(74)80355-0 · Cited by 50
Optimizing Estrogen Replacement Treatment in Turner Syndrome
Rosenfield, R. L., Perovic, N., Devine, N. A., Mauras, N., Moshang, T., Root, A. W., & Sy, J. P. (1998) · PEDIATRICS · doi:10.1542/peds.102.s3.486 · Cited by 48
McDonnell, C. M., Coleman, L. T., & Zacharin, M. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01737.x · Cited by 45
Bone mineralization in Turner syndrome: a transverse study of the determinant factors in 58 patients
Costa, A. M. G., de Lemos‐Marini, S. H. V., Baptista, M. T. M., Morcillo, A. M., Maciel‐Guerra, A. T., & Guerra‐Júnior, G. (2002) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740200042 · Cited by 40
Gussinyé, M., Terrades, P., Yeste, D., Vicens-Calvet, E., & Carrascosa, A. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053246 · Cited by 24
Pelvic ultrasound evaluation in patients with Turner syndrome during treatment with growth hormone
Sampaolo, P., Calcaterra, V., Klersy, C., Alfei, A., Leonardis, C., Maino, M., & Larizza, D. (2003) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.144 · Cited by 18
Optimizing Estrogen Replacement in Adolescents with Turner Syndrome
Rosenfield, R. L., Perovic, N., & Devine, N. A. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06232.x · Cited by 2
Flagged first, then by citations
1 of the 37 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
ESHRE Guideline: management of women with premature ovarian insufficiency
The ESHRE Guideline Group on POI, Webber, L. J., Davies, M. C., Anderson, R. A., Bartlett, J., Braat, D. D. M., Cartwright, B., Cífková, R., Keizer‐Schrama, S. D. M., Hogervorst, E., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew027 · Cited by 1,603
Gravholt, C. H., Andersen, N. H., Conway, G. S., Dekkers, O. M., Geffner, M. E., Klein, K. O., Lin, A. E., Mauras, N., Quigley, C. A., Rubin, K., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0430 · Cited by 1,101
Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa
Misra, M., Katzman, D. K., Miller, K. K., Mendes, N., Snelgrove, D., Russell, M., Goldstein, M. A., Ebrahimi, S., Clauss, L., Weigel, T. J., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.447 · Cited by 354
Approach to the Patient with Turner Syndrome
Davenport, M. L. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0926 · Cited by 252
Clinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae050 · Cited by 224
Metadata
- Authors
- Nabhan, Z. M., DiMeglio, L. A., Qi, R., Perkins, S. M., & Eugster, E. A.
- Affiliations
- Indiana University Hospital (US)
- Indiana University Indianapolis (US)
- Riley Hospital for Children (US)
- Corresponding author
- Nabhan, Zeina M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-06-01
- Volume
- 94
- Issue
- 6
- Pages
- 2009-2014
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2120922659
- Cited by
- 119
- References
- 37
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 9 · 2021: 3 · 2020: 6 · 2019: 15 · 2018: 6 · 2017: 9 · 2016: 5 · 2015: 8 · 2014: 12 · 2013: 9 · 2012: 4
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- Turner syndrome, estrogen replacement therapy, transdermal estrogen, bone mineral accrual, uterine growth, pubertal development, insulin-like growth factor I, lipid profile
- MeSH terms
- Administration, Cutaneous, Administration, Oral, Adolescent, Body Composition, Bone Development, Child, Estrogens, Conjugated (USP), Female, Humans, Insulin-Like Growth Factor I, Lipids, Pilot Projects, Puberty, Turner Syndrome, Uterus, Bone Density, Estrogen Replacement Therapy, Adolescent Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
